Literature DB >> 7648592

Femoropopliteal artery recanalization: factors affecting clinical outcome of conventional and laser-assisted balloon angioplasty.

H F Odink1, H C de Valois, B C Eikelboom.   

Abstract

PURPOSE: The clinical efficacy of 44 successful conventional and laser-assisted recanalizations of the femoropopliteal artery was assessed in a noncomparative study by the life-table method.
METHODS: Laser-assisted angioplasty using continuous laser and a sapphire probe was performed to achieve primary recanalization in femoral artery occlusions when conventional guidewire recanalization had already failed. Nineteen of the patients underwent a conventional recanalization (PTA; mean length of occlusion 4.4 +/- 4.1 cm), and 25 underwent percutaneous laser-assisted angioplasty (PLA; mean length of occlusion 10.1 +/- 6.7 cm).
RESULTS: There was no statistical relation between the preprocedure Fontaine classification and the success rate in the PTA cases (p = 0.25), whereas there was a statistical relation in the PLA cases: The success rate in patients preprocedurally classified as Fontaine II was better than in those classified as Fontaine III/IV (p = 0.05). After a 3-year follow-up the patency rate in the patients with the PTA recanalizations was 37% and that in those with the PLA procedure was 53%. This difference was not statistically significant (p = 0.47).
CONCLUSION: It is concluded that the laser should remain an investigational device.

Entities:  

Mesh:

Year:  1995        PMID: 7648592     DOI: 10.1007/bf00204143

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  20 in total

1.  Vascular interventional radiologists, the development of new technologies, marketing, and the auk.

Authors:  G M Gaylord
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

2.  Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease.

Authors:  R B Rutherford; G J Becker
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

3.  Laser angioplasty: results of a prospective, multicenter study at 3-year follow-up.

Authors:  J Lammer; E Pilger; F Karnel; H Schurawitzki; W Horvath; M Riedl; H Umek; G E Klein; H Schreyer; G Kretschmer
Journal:  Radiology       Date:  1991-02       Impact factor: 11.105

4.  Efficiency and safety of optically modified fiber tips for laser angioplasty.

Authors:  H J Geschwind; M J Kern; M G Vandormael; J D Blair; U Deligonul; H L Kennedy
Journal:  J Am Coll Cardiol       Date:  1987-09       Impact factor: 24.094

5.  Long-segment femoropopliteal stenoses: is angioplasty a boon or a bust?

Authors:  R R Murray; R C Hewes; R I White; S E Mitchell; M Auster; R Chang; S Kadir; M L Kinnison; S L Kaufman
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

6.  Percutaneous laser thermal angioplasty: initial results and 1-year follow-up in 129 femoropopliteal lesions.

Authors:  T A Sanborn; D C Cumberland; A J Greenfield; C L Welsh; J K Guben
Journal:  Radiology       Date:  1988-07       Impact factor: 11.105

7.  Artificial sapphire probe for contact photocoagulation and tissue vaporization with the Nd:YAG laser.

Authors:  N Daikuzono; S N Joffe
Journal:  Med Instrum       Date:  1985 Jul-Aug

8.  Comparison of pulsed laser-assisted angioplasty and balloon angioplasty in femoropopliteal artery occlusions.

Authors:  P E Huppert; S H Duda; U Helber; K R Karsch; C D Claussen
Journal:  Radiology       Date:  1992-08       Impact factor: 11.105

9.  Angioplasty for femoral artery occlusion: comparison with surgery.

Authors:  E C Martin; E I Fankuchen; K B Karlson; C Dolgin; R H Collins; A B Voorhees; W J Casarella
Journal:  AJR Am J Roentgenol       Date:  1981-11       Impact factor: 3.959

10.  Femoropopliteal arterial occlusions: laser-assisted versus conventional percutaneous transluminal angioplasty.

Authors:  H F Odink; H C de Valois; B C Eikelboom
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.